rhodium has been researched along with Bacterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Dong, R; Hu, F; Jia, Y; Jiang, X; Liu, S; Tang, H; Zhao, X | 1 |
| Bandow, JE; Cheng, X; Dabiri, Y; Hager, L; Keppler, BK; Ott, I; Prochnow, P; Streciwilk, W; Terenzi, A; Wölfl, S | 1 |
2 other study(ies) available for rhodium and Bacterial Disease
| Article | Year |
|---|---|
Bimetallic nanoparticles against multi-drug resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Gold; Human Umbilical Vein Endothelial Cells; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Rats, Sprague-Dawley; Rhodium; Ruthenium; Staphylococcus aureus | 2020 |
Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorescent Dyes; G-Quadruplexes; Humans; Intercalating Agents; Ligands; Naphthalimides; Neoplasms; Organometallic Compounds; Rhodium; Ruthenium | 2018 |